Euclide M 60 OD Tablet ER
By Euclide M
Rx
10 Tablet ER in a Strip

Composition
Gliclazide(60mg) + Metformin(500mg)

Manufacturer - Alkem Laboratories Ltd
Alkem Laboratories Limited, Devashish Building, Alkem House, Senapati Bapat Road, Lower Parel, Mumbai - 400 013.

Expires on or after
June, 2026

liver
When it comes to the safety of Glytas M 60mg/500mg Tablet ER in relation to liver issues, it is important to exercise caution. Patients with liver disease should be careful when using this medication. It may be necessary to adjust the dose of Glytas M 60mg/500mg Tablet ER in such cases. It is advisable to consult your doctor before starting this medication. Typically, Glytas M 60mg/500mg Tablet ER is initiated at a low dose for individuals with mild to moderate liver disease. However, it is not recommended for use in patients with severe liver disease. If you have any liver concerns, it's crucial to seek guidance from your healthcare provider before using Glytas M 60mg/500mg Tablet ER.

kidney
Glytas M 60mg/500mg Tablet ER should be used carefully if you have kidney disease. Your doctor may need to adjust the dose. It is not recommended for severe kidney disease. Regular monitoring of kidney function is advised during treatment.

alcohol
Do not drink alcohol while taking Glytas M 60mg/500mg Tablet ER.

driving
Caution Avoid driving if blood sugar levels are too low or high, as it can impact focus and reaction times.

pregnancy
Glytas M 60mg/500mg Tablet ER is not recommended during pregnancy as it may pose risks to the developing baby. Only use if prescribed in life-threatening situations after consulting your doctor.

breastfeeding
Caution is advised while breastfeeding as Glytas M 60mg/500mg Tablet ER may not be safe. Limited evidence indicates potential harm to the baby through breastmilk.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹165
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024